Latest News Nine Drug Formularies In Canada List Evenity® For Reimbursement For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk Of Fracture April 3, 2024 Amgen Canada has […]

UPDATE As the COVID-19 situation and directives from public health agencies continue to evolve quickly, the Tamarack Ottawa Race Weekend and Scotiabank Ottawa Marathon have decided to temporarily pause new […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

This report provides a national overview on diagnosed osteoporosis, related fractures and the osteoporosis care gap among Canadians 40 years and older.  It reports on administrative data from the Canadian […]

Latest News PHAC Osteoporosis Key Findings August 18, 2021 Osteoporosis Canada has been working closely with the Public Health Agency of Canada (PHAC) over the past few years assisting in […]

Our family and friends can form a valuable support team for us as we work through the challenges of living life with osteoporosis. They can be both cheerleaders and caregivers […]

Everyone has at one time experienced acute pain. The recent article on “Osteoporosis and Pain-Helping Your Body Help Itself” explains acute pain as a pain that starts suddenly and has […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]